S.horowits_Logo

News & Insightse

Filter by

Or

Updates
4 min. read

Update to Procedure No. 6 of the Ministry of Health – A Breakthrough in Pharmacovigilance Policy?

The Department of Risk Management and Medicinal Information at the Israeli Ministry of Health has published, for the public comments, a draft update to procedure No. 6, titled “Reporting of Adverse Events and New Safety Information”.
Read

Updates
8 min. read

Limit Your Expectations to Get Around the Statute of Limitation

A dispute between two pharmaceutical manufacturers gave rise to an important ruling by the Supreme Court on key issues with respect to Israeli statute of limitation (C.A, 5474/18 Unipharm Ltd. v. Glaxo SmitkKline p.l.c (18.6.2024).
Read

Articles
1 min. read

The revolution in the Israeli Patent Law was confirmed, once again, by the Supreme Court?

The Israeli Supreme Court’s decision in Sanofi v. Unipharm (December 26, 2023) marks a key development in patent law and the Unjust Enrichment Law. 
Read

Articles
1 min. read

Novartis’ PI Motion re Gilenya® Denied: Generic Entry Does Not Necessarily Cause “Catastrophic Damages” to the Brand

The Israeli Tax Authority has issued groundbreaking guidance on SAFE instruments, providing much-needed clarity for venture capital investments.
Read

Position Application

Subscribe

Get the latest updates straight to your inbox